Akèy › Pwoblèm Ren Dyabetik
Etid klinik pou Pwoblèm Ren Dyabetik ap rekrite nan Etazini
17 etid pou Pwoblèm Ren Dyabetik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Seattle, WA5 etid
- Chicago, IL4 etid
- San Antonio, TX4 etid
- Aurora, CO3 etid
- Philadelphia, PA3 etid
- New York City, NY3 etid
Pa eta
- Colorado4 etid
- Florid4 etid
- Illinois5 etid
- Kalifòni5 etid
- New York5 etid
- Pennsylvania3 etid
- Texas5 etid
- Washington5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Long-Term Follow-Up Study of Participants Exposed to REACT
Ap rekriteEtid obsèvasyon
Laj 30 a 80 · Tout sèks · Mizajou Sep 1, 2026 · NCT05918523Real World Evidence Clinical Utility Study of KidneyIntelX
Ap rekriteEtid obsèvasyon
Laj 23 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT04802395A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Aug 12, 2026 · NCT07024823Study of WAL0921 in Patients With Glomerular Kidney Diseases
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT06466135Mechanism of SGLT2 Inhibition in the Kidney
Ap rekriteFaz 4Mande peman pou patisipan yo
Laj 18 a 80 · Tout sèks · Mizajou Jun 11, 2026 · NCT06291155Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT05822609NAD Augmentation in Diabetes Kidney Disease
Ap rekriteFaz 2
Laj 30 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT05759468Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302Transformative Research in Diabetic Nephropathy 2.0
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT07444203Transformative Research in Diabetic Nephropathy
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Feb 27, 2026 · NCT02986984Formoterol in Diabetes
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Feb 5, 2026 · NCT07022418Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT06752577MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
Ap rekriteFaz 1
Laj 12 a 25 · Tout sèks · Mizajou Jun 13, 2025 · NCT05065372Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
Ap rekrite
Laj 14 a 40 · Tout sèks · Mizajou Jun 13, 2025 · NCT06936670Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 4, 2025 · NCT01802034Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 8 a 14 · Tout sèks · Mizajou Mar 24, 2025 · NCT05008276Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.